This trial is active, not recruiting.

Condition healthy
Treatment mri magnetic resonance imaging
Sponsor University of Michigan
Collaborator General Electric
Start date May 2011
End date December 2015
Trial size 20 participants
Trial identifier NCT00738712, HUM00041815


This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic
New hardware or software technologies designed to improve MRI examinations.
mri magnetic resonance imaging Magnetic Resonance Imaging

Primary Outcomes

Evaluation of new software in MRI vascular imaging
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - male or non-pregnant female patient - 18 years or older - any ethnic background - presenting to MRI for a clinically-ordered chest MRI exam. Exclusion Criteria: - Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. - Pregnant patients or patients who are lactating. - A patient who is claustrophobic

Additional Information

Official title Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
Trial information was received from ClinicalTrials.gov and was last updated in December 2015.
Information provided to ClinicalTrials.gov by University of Michigan.